ATR-107
ATR-107 is a humanized monoclonal antibody inhibitor targeting interleukin-21 receptor (IL-21R) . ATR-107 is promising for research of autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus[1].
Product Specifications
Product Name Alternative
PF-05230900
UNSPSC
12352203
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Purity
98.62
Molecular Weight
(143.42 kDa)
References & Citations
[1]Hua F, et al. Anti-IL21 receptor monoclonal antibody (ATR-107) : Safety, pharmacokinetics, and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study. J Clin Pharmacol. 2014 Jan;54 (1) :14-22.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
138250-ML750 100 µL
Prostate Specific Antigen (Prostate-specific Antigen, PSA, APS, Gamma-seminoprotein, Kallikrein-3, KLK3, hK3, KLK2A1, P-30 Antigen, Seminin, Semenogelase) (MaxLight 750) discontinued
Ask
View Details 